Condition: Drug-induced Liver Injury · Sponsor: Beijing Friendship Hospital
A prospective, multi-center, non-interventional cohort study is going to conduct to explore the clinical characteristics, culprit drug(s) or herb(s), outcomes and risk factors of Drug-induced liver injury (DILI) in China and screen novel serum markers. A prognostic model incorporating with the novel serum marker(s) for DILI would be established and validated to imporve the prognosis of patients in China .
This description comes directly from the study's public registry record.
Yan Wang · 18810530724 · wangyanpku@163.com
Zikun Ma · 18311270304 · maazikun0114@163.com
Always discuss trial participation with your own doctor first.
| Beijing 302 Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Beijing Friendship Hospital, Capital Medical University | Beijing, China | Recruiting |
| Beijing You 'an Hospital, Capital Medical University | Beijing, China | Recruiting |
| Beijing Ditan Hospital | Beijing, China | Active Not Recruiting |
| Peking University Third Hospital | Beijing, China | Active Not Recruiting |
| The Second Affiliated Hospital of Dalian Medical University | Dalian, China | Recruiting |
| Qinzhou First People's Hospital | Guangxi, China | Active Not Recruiting |
| Hebei CNPC Central Hospital | Hebei, China | Active Not Recruiting |
| Jiaozuo People's Hospital | Jiaozuo, China | Recruiting |
| The Second Hospital of Lanzhou University | Lanzhou, China | Recruiting |
| The Affiliated Hospital of Qingdao University | Qingdao, China | Recruiting |
| Qinghai People's Hospital | Qinghai, China | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05060289